Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Abstract Objectives Rheumatoid arthritis (RA) patients have an increased risk of cardiovascular disease (CVD). In the present study, we evaluated the inflammatory activity of the ascending aorta in RA patients who received biological treatment. Methods We assessed the aortic wall inflammation of RA...
Main Authors: | D. A. M. Thuy Trang, Koichi Okamura, Takahito Suto, Hideo Sakane, Yukio Yonemoto, Takahito Nakajima, Yoshito Tsushima, Hirotaka Chikuda |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-08-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13075-021-02585-w |
Similar Items
-
Does periodontitis affect the treatment response of biologics in the treatment of rheumatoid arthritis?
by: Masahiro Tachibana, et al.
Published: (2020-07-01) -
Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
by: Tetsuya Kaneko, et al.
Published: (2019-10-01) -
Anti-drug antibodies and rheumatoid factor level in patients with rheumatoid arthritis using the infliximab biosimilar CT-P13
by: Hideo Sakane, et al.
Published: (2022-12-01) -
Quantifying disease activity in rheumatoid arthritis with the TSPO PET ligand 18F-GE-180 and comparison with 18F-FDG and DCE-MRI
by: Marius de Groot, et al.
Published: (2019-12-01) -
Assessment of large joint destruction in patients with rheumatoid arthritis using FDG-PET/CT
by: Takahito Suto, et al.
Published: (2016-10-01)